GDRX
GoodRx Holdings, Inc.
Overview
GoodRx Holdings, Inc. operates a digital healthcare platform that aggregates prescription pricing data from pharmacies, pharmacy benefit managers, and other sources to help consumers find and access lower-cost medications.
GoodRx Holdings, Inc is a Healthcare company operating in Health Information Services with a $870.4M market cap.
Most recent reported earnings: Q2 FY2026 (Aug 4, 2026).
21 earnings calls indexed on Spoken Alpha.
Behavioral analysis
Management language signature
Disclosures
Investor Relations
Extracted from Unknown source, 2026-06-21.
Transcripts
Recent earnings calls
Most recent calls indexed for this ticker. Open any call to drill into prepared remarks and Q&A.
- Q1 FY2026Earnings2026-05-0818 Q&A exchanges
- Q4 FY2025Earnings2026-02-2622 Q&A exchanges
- Q3 FY2025Earnings2025-11-0518 Q&A exchanges
- Q2 FY2025Earnings2025-08-0817 Q&A exchanges
- Q1 FY2025Earnings2025-05-0825 Q&A exchanges
- Q4 FY2024Earnings2025-02-2718 Q&A exchanges
- Q3 FY2024Earnings2024-11-0714 Q&A exchanges
- Q2 FY2024Earnings2024-08-0826 Q&A exchanges
- Q1 FY2024Earnings2024-05-0917 Q&A exchanges
- Q4 FY2023Earnings2024-02-2922 Q&A exchanges
- Q3 FY2023Earnings2023-11-0915 Q&A exchanges
- Q2 FY2023Earnings2023-08-0922 Q&A exchanges
- Q1 FY2023Earnings2023-05-1026 Q&A exchanges
- Q4 FY2022Earnings2023-02-2824 Q&A exchanges
- Q3 FY2022Earnings2022-11-0815 Q&A exchanges
- Q2 FY2022Earnings2022-08-0816 Q&A exchanges
- Q1 FY2022Earnings2022-05-0917 Q&A exchanges
- Q4 FY2021Earnings2022-02-2813 Q&A exchanges
- Q3 FY2021Earnings2021-11-1011 Q&A exchanges
- Q2 FY2021Earnings2021-08-1225 Q&A exchanges
- Q1 FY2021Earnings2021-05-1415 Q&A exchanges
History
Earnings history
- Q2 FY20262026-08-04EPS— vs $0.08—Rev— vs ——EODHD
- Q1 FY20262026-05-06EPS$0.07 vs $0.10-28.9%Rev$194.0M vs ——EODHD
- Q4 FY20252026-02-24EPS$0.09 vs $0.09-1.8%Rev$194.8M vs ——EODHD
- Q3 FY20252025-11-03EPS$0.08 vs $0.09-11.1%Rev$196.0M vs ——EODHD
- Q2 FY20252025-08-05EPS$0.09 vs $0.10-10.0%Rev$203.1M vs ——EODHD
- Q1 FY20252025-05-06EPS$0.09 vs $0.10-6.0%Rev$203.0M vs ——EODHD
- Q4 FY20242025-02-25EPS$0.09 vs $0.10-6.2%Rev$198.6M vs ——EODHD
- Q3 FY20242024-11-06EPS$0.08 vs $0.09-11.1%Rev$195.3M vs ——EODHD
- Q2 FY20242024-08-07EPS$0.08 vs $0.09-11.1%Rev$200.6M vs ——EODHD
- Q1 FY20242024-05-08EPS$0.08 vs $0.080.0%Rev$197.9M vs ——EODHD
- Q4 FY20232024-02-28EPS$0.08 vs $0.07+14.3%Rev$196.6M vs ——EODHD
- Q3 FY20232023-11-08EPS$0.06 vs $0.060.0%Rev$180.0M vs ——EODHD
- Q2 FY20232023-08-08EPS$0.07 vs $0.06+16.7%Rev$189.7M vs ——EODHD
- Q1 FY20232023-05-09EPS$0.07 vs $0.06+16.7%Rev$184.0M vs ——EODHD
- Q4 FY20222023-02-27EPS$0.07 vs $0.05+40.0%Rev$184.1M vs ——EODHD
- Q3 FY20222022-11-07EPS$0.07 vs $0.04+75.0%Rev$187.3M vs ——EODHD
- Q2 FY20222022-08-07EPS$0.06 vs $0.04+50.0%Rev$191.8M vs ——EODHD
- Q1 FY20222022-05-08EPS$0.10 vs $0.08+25.0%Rev$203.3M vs ——EODHD
- Q4 FY20212022-02-27EPS$0.09 vs $0.10-10.0%Rev$213.3M vs ——EODHD
- Q3 FY20212021-11-09EPS$0.09 vs $0.090.0%Rev$195.1M vs ——EODHD
| Period | Reported | EPS actual | EPS consensus | EPS surprise | Revenue actual | Revenue consensus | Rev. surprise | Source |
|---|---|---|---|---|---|---|---|---|
| Q2 FY2026 | 2026-08-04 | — | $0.08 | — | — | — | — | EODHD |
| Q1 FY2026 | 2026-05-06 | $0.07 | $0.10 | -28.9% | $194.0M | — | — | EODHD |
| Q4 FY2025 | 2026-02-24 | $0.09 | $0.09 | -1.8% | $194.8M | — | — | EODHD |
| Q3 FY2025 | 2025-11-03 | $0.08 | $0.09 | -11.1% | $196.0M | — | — | EODHD |
| Q2 FY2025 | 2025-08-05 | $0.09 | $0.10 | -10.0% | $203.1M | — | — | EODHD |
| Q1 FY2025 | 2025-05-06 | $0.09 | $0.10 | -6.0% | $203.0M | — | — | EODHD |
| Q4 FY2024 | 2025-02-25 | $0.09 | $0.10 | -6.2% | $198.6M | — | — | EODHD |
| Q3 FY2024 | 2024-11-06 | $0.08 | $0.09 | -11.1% | $195.3M | — | — | EODHD |
| Q2 FY2024 | 2024-08-07 | $0.08 | $0.09 | -11.1% | $200.6M | — | — | EODHD |
| Q1 FY2024 | 2024-05-08 | $0.08 | $0.08 | 0.0% | $197.9M | — | — | EODHD |
| Q4 FY2023 | 2024-02-28 | $0.08 | $0.07 | +14.3% | $196.6M | — | — | EODHD |
| Q3 FY2023 | 2023-11-08 | $0.06 | $0.06 | 0.0% | $180.0M | — | — | EODHD |
| Q2 FY2023 | 2023-08-08 | $0.07 | $0.06 | +16.7% | $189.7M | — | — | EODHD |
| Q1 FY2023 | 2023-05-09 | $0.07 | $0.06 | +16.7% | $184.0M | — | — | EODHD |
| Q4 FY2022 | 2023-02-27 | $0.07 | $0.05 | +40.0% | $184.1M | — | — | EODHD |
| Q3 FY2022 | 2022-11-07 | $0.07 | $0.04 | +75.0% | $187.3M | — | — | EODHD |
| Q2 FY2022 | 2022-08-07 | $0.06 | $0.04 | +50.0% | $191.8M | — | — | EODHD |
| Q1 FY2022 | 2022-05-08 | $0.10 | $0.08 | +25.0% | $203.3M | — | — | EODHD |
| Q4 FY2021 | 2022-02-27 | $0.09 | $0.10 | -10.0% | $213.3M | — | — | EODHD |
| Q3 FY2021 | 2021-11-09 | $0.09 | $0.09 | 0.0% | $195.1M | — | — | EODHD |
Source: EODHD. GDRX reported actuals as published; sparse fields render as —.
Track Record
SampleSpoken Alpha tracks GDRX's historical accountability: how often management beat consensus, how the stock reacted, and how guidance evolved across the cycle. The figures below are illustrative placeholder data generated for layout — they will be replaced with real deviation metrics, True Consensus values, and EODHD price reactions as those data layers land.
Beats consensus 10/10 quarters with 50% positive reaction rate
SampleConsistent execution against consensus with the stock following through is the cleanest signal a guidance regime is calibrated. Worth watching for the inflection where execution deteriorates relative to the bar.
Raised guidance 8 quarters in a row
SampleConsecutive raises tighten the bar quarter over quarter. Watch the most recent print for the magnitude of the beat — a smaller beat against a higher bar is the early signal that the regime is breaking.
Quarterly beats & misses
Sample| Quarter | Actual EPS | Consensus | Surprise | 1D | 5D |
|---|---|---|---|---|---|
| Q1 FY2026 | $4.63 | $3.22 | +43.7% | +4.1% | +6.3% |
| Q4 FY2026 | $4.78 | $3.20 | +49.5% | -6.0% | -4.7% |
| Q3 FY2026 | $4.93 | $3.28 | +50.2% | +3.9% | +3.9% |
| Q2 FY2026 | $5.04 | $3.36 | +50.1% | -0.3% | +1.0% |
| Q1 FY2025 | $4.71 | $3.27 | +43.9% | -6.5% | -5.7% |
| Q4 FY2025 | $4.84 | $3.26 | +48.6% | +2.3% | +4.6% |
| Q3 FY2025 | $4.62 | $3.26 | +41.6% | -0.8% | -2.2% |
| Q2 FY2025 | $4.94 | $3.42 | +44.4% | +1.7% | +1.8% |
| Q1 FY2024 | $4.99 | $3.28 | +52.0% | -3.3% | -1.1% |
| Q4 FY2024 | $4.85 | $3.26 | +48.7% | +2.7% | +3.4% |
Guidance change history
Sample- Q1 FY2026Raised2026-04-15
- Q4 FY2026Raised2026-13-15
- Q3 FY2026Raised2026-10-15
- Q2 FY2026Raised2026-07-15
- Q1 FY2025Raised2025-04-15
- Q4 FY2025Raised2025-13-15
- Q3 FY2025Raised2025-10-15
- Q2 FY2025Raised2025-07-15
Top executives
SampleSpoken Alpha builds an accountability record per executive — how the person's own guidance, language, and reactions have evolved across every call they've appeared on. The one-liners below are illustrative placeholder data pending the deviation v1 work. Click any name for the full role timeline and call appearance history.
- Thomas (tc) ChanChief Accounting Officer2 mono recorded callsCurrentSample
OTHER_C_SUITE since 2026 • 1/2 beats (50%) • last guidance raise Q1 FY2026
- Romin NabieyChief Accounting Officer4 yr 2 mono recorded callsCurrentSample
OTHER_C_SUITE since 2022 • 13/16 beats (81%) • last guidance cut Q3 FY2026
- Christopher A McGinnisSee Remarks4 mo6 callsCurrentSample
OTHER since 2026 • 2/2 beats (100%) • guidance suspended Q2 FY2026
- Wendy Lynn BarnesSee Remarks5 mono recorded callsCurrentSample
OTHER since 2026 • 1/2 beats (50%) • last call held guidance Q3 FY2026
Peers
Other companies in Healthcare
Sector peers tracked by Spoken Alpha. Each links to the same machine-readable IR surface — earnings calls, executives, and accountability scores.
API
For developers and AI agents
The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for GDRX.
$ curl https://api.spokenalpha.com/v1/companies/GDRXFAQ
Frequently asked about GDRX
Where can I find GoodRx Holdings, Inc.'s (GDRX) earnings call transcripts?
Spoken Alpha indexes GDRX's earnings call transcripts at https://spokenalpha.com/companies/GDRX. Each call links to attributed speakers and parsed analyst Q&A. GoodRx Holdings, Inc.'s own investor relations page is at https://investors.goodrx.com/.
When was GoodRx Holdings, Inc.'s most recent earnings call?
GoodRx Holdings, Inc. (GDRX) held its most recent earnings call on 2026-05-08, covering fiscal Q1 2026.
What sector is GDRX in?
GoodRx Holdings, Inc. (GDRX) operates in the Healthcare sector (Health Information Services industry).